Tulathromycin
Systematic (IUPAC) name | |
---|---|
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyrano-syl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 217500-96-4 |
ATCvet code | QJ01FA94 |
ChemSpider | 24583287 |
UNII | Q839I13422 |
KEGG | D06258 |
Chemical data | |
Formula | C41H79N3O12 |
Molar mass | 806.08 g/mol |
| |
| |
(verify) |
Tulathromycin is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs. It is marketed by Pfizer Inc. under the tradename Draxxin.
It is supplied as a solution for injection containing 100 mg of the drug. [1]
References
External links
This article is issued from Wikipedia - version of the Friday, September 02, 2011. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.